Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.31M Buy
37,000
+3,073
+9% +$661K 0.27% 57
2026
Q1
$7.38M Buy
33,927
+4,667
+16% +$1.04M 0.26% 58
2025
Q4
$6.69M Buy
29,260
+1,385
+5% +$316K 0.25% 54
2025
Q3
$6.45M Buy
27,875
+3,284
+13% +$669K 0.26% 51
2025
Q2
$4.56M Buy
24,591
+377
+2% +$70.1K 0.21% 58
2025
Q1
$5.07M Buy
24,214
+5,284
+28% +$1.03M 0.27% 53
2024
Q4
$3.36M Buy
18,930
+5,926
+46% +$1.09M 0.19% 63
2024
Q3
$2.57M Buy
13,004
+406
+3% +$75.8K 0.16% 77
2024
Q2
$2.16M Buy
12,598
+1,186
+10% +$196K 0.15% 83
2024
Q1
$2.08M Buy
11,412
+2,136
+23% +$368K 0.15% 83
2023
Q4
$1.44M Buy
9,276
+4,603
+99% +$671K 0.12% 99
2023
Q3
$697K Sell
4,673
-1,411
-23% -$207K 0.07% 138
2023
Q2
$820K Sell
6,084
-753
-11% -$110K 0.08% 131
2023
Q1
$1.09M Sell
6,837
-214
-3% -$32.7K 0.12% 101
2022
Q4
$1.14M Sell
7,051
-1,219
-15% -$187K 0.15% 86
2022
Q3
$1.11M Buy
8,270
+363
+5% +$52.1K 0.17% 73
2022
Q2
$1.21M Sell
7,907
-327
-4% -$50K 0.19% 68
2022
Q1
$1.33M Buy
8,234
+3,010
+58% +$437K 0.23% 61
2021
Q4
$707K Buy
5,224
+2,245
+75% +$265K 0.13% 97
2021
Q3
$321K Buy
+2,979
New +$340K 0.07% 121
2019
Q2
Sell
-2,968
Closed -$239K 91
2019
Q1
$239K Hold
2,968
0.1% 74
2018
Q4
$274K Buy
+2,968
New +$261K 0.13% 67

Other funds holding ABBV

Zhang Financial's ABBV Position: Q2 2026 in Review

Zhang Financial increased its AbbVie (ABBV) stake by 9.1% in Q2 2026, buying an estimated $661K and bringing the position to 37,000 shares worth $9.31M. The position accounts for 0.27% of the portfolio, ranked #57.

Zhang Financial first reported a position in ABBV in Q4 2018 and has held it in 22 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Zhang Financial held 37,000 shares of AbbVie worth $9.31M as of Q2 2026.
  • Zhang Financial bought 3,073 AbbVie shares in Q2 2026, an estimated $661K.
  • AbbVie made up 0.27% of Zhang Financial's portfolio in Q2 2026, its #57 holding.
  • Zhang Financial first reported a position in AbbVie in Q4 2018 and has held it in 22 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Zhang Financial's 13F filing for Q2 2026, filed 30 Jul 2026.